Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record now shows the study is Completed and no longer looking for participants, with the Recruitment Status and Study Status sections updated accordingly to reflect the end of recruitment.SummaryDifference2%

- Check18 days agoChange DetectedA new revision entry Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This indicates an update to the page's version history.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history now shows a new revision, v3.5.4, as the latest entry, replacing the prior v3.5.3. This reflects a minor update to the page's version history rather than content changes.SummaryDifference0.1%

- Check61 days agoChange DetectedA minor update to the ClinicalTrials.gov page’s revision/version indicator is shown (v3.5.2 → v3.5.3). This reflects a platform or release change rather than a change to the underlying trial record.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision 3.5.2 was added to the history and Revision 3.5.0 was removed.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded site revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.